Article
Bendamustine is effective in p53-deficient B-cell neoplasms and requires oxidative stress and caspase-independent signaling.
Clinical cancer research : an official journal of the American Association for Cancer Research - 1 Nov 2008
Roué Gaël, López-Guerra Mónica, Milpied Pierre, Pérez-Galán Patricia, Villamor Neus, Montserrat Emili, Campo Elias, Colomer Dolors
Abstract excerpt
PURPOSE: Chronic lymphocytic leukemia (CLL) and mantle cell lymphoma (MCL) are two incurable B-cell lymphoid neoplasms characterized by distinct clinical presentation and evolution. Bendamustine hydrochloride is a multifunctional, alkylating agent with a purine-like ring system that exhibits acti...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
